Search

everythinglearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Metoprolol and propranolol may cause hair loss.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

Tofacitinib may help regrow hair in alopecia areata patients.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Tofacitinib might be used to treat hair loss.

Regulatory challenges make developing combination therapies in urology difficult and costly.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Oral 5-alpha-reductase inhibitors for hair loss don't increase heart risk.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.